REPH insider filings
Recro Pharma, Inc. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2022-03-17. Screen REPH transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for REPH between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.
Recent insider filings — Recro Pharma, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2022-03-17 | 4 | ENLOE J DAVID JR — Chief Executive Officer, Director | Purchase (P): 512 @ $1.96 | EDGAR |
| 2022-02-17 | 4 | ENLOE J DAVID JR — Chief Executive Officer, Director | Purchase (P): 571 @ $1.77 | EDGAR |
| 2022-02-04 | 4 | Lake Ryan David — Chief Financial Officer | Tax withholding (F): 1,021 @ $1.54 | EDGAR |
| 2022-02-02 | 4 | Lake Ryan David — Chief Financial Officer | Tax withholding (F): 1,419 @ $1.54 | EDGAR |
| 2022-01-24 | 4 | Lake Ryan David — Chief Financial Officer | Grant/award (A): 39,604 · Grant/award (A): 169,697 @ $0 · Grant/award (A): 247,788 (derivative) @ $0 | EDGAR |
| 2022-01-24 | 4 | ENLOE J DAVID JR — Chief Executive Officer, Director | Grant/award (A): 66,007 · Grant/award (A): 303,030 @ $0 · Grant/award (A): 442,478 (derivative) @ $0 | EDGAR |
| 2022-01-19 | 4 | Lake Ryan David — Chief Financial Officer | Tax withholding (F): 1,094 @ $1.65 | EDGAR |
| 2022-01-19 | 4 | ENLOE J DAVID JR — Chief Executive Officer, Director | Purchase (P): 602 @ $1.68 | EDGAR |
| 2022-01-04 | 4 | Lake Ryan David — Chief Financial Officer | Tax withholding (F): 28,730 @ $1.71 · Tax withholding (F): 979 @ $1.74 | EDGAR |
| 2021-12-23 | 4 | AWM Investment Company, Inc. — 10% owner | Sale (S): 99,398 @ $1.55 | EDGAR |
| 2021-12-20 | 4 | AWM Investment Company, Inc. — 10% owner | Sale (S): 50,000 @ $1.61 | EDGAR |
| 2021-12-17 | 4 | Lake Ryan David — Chief Financial Officer | Tax withholding (F): 5,690 @ $1.61 | EDGAR |
| 2021-12-17 | 4 | ENLOE J DAVID JR — Chief Executive Officer, Director | Purchase (P): 617 @ $1.61 | EDGAR |
| 2021-12-15 | 4 | AWM Investment Company, Inc. — 10% owner | Sale (S): 20,000 @ $1.63 · Sale (S): 10,602 @ $1.57 · Sale (S): 20,000 @ $1.63 | EDGAR |
| 2021-11-19 | 4 | Miller James Charles — Director | Purchase (P): 1,000 @ $1.69 | EDGAR |
| 2021-11-16 | 4 | Lake Ryan David — Chief Financial Officer | Purchase (P): 1,162 @ $1.65 · Purchase (P): 50 @ $1.62 | EDGAR |
| 2021-11-16 | 4 | ENLOE J DAVID JR — Chief Executive Officer, Director | Purchase (P): 1,725 @ $1.68 | EDGAR |
| 2021-07-13 | 4 | Lake Ryan David — Chief Financial Officer | Tax withholding (F): 5,172 @ $1.96 | EDGAR |
| 2021-06-21 | 4 | Parks Laura L. — Director | Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2021-06-14 | 4 | AWM Investment Company, Inc. — 10% owner | Sale (S): 150,000 @ $2.23 · Sale (S): 50,000 @ $2.16 · Sale (S): 266,667 @ $2.20 | EDGAR |
| 2021-06-08 | 4 | Lake Ryan David — Chief Financial Officer | Option exercise (M): 2,500 · Tax withholding (F): 719 @ $2.30 · Option exercise (M): 2,500 (derivative) @ $0 | EDGAR |
| 2021-05-17 | 4/A | Weisman Wayne — Director | Grant/award (A): 38,012 (derivative) @ $0 | EDGAR |
| 2021-05-17 | 4/A | CHURCHILL WINSTON J — Director | Grant/award (A): 38,012 (derivative) @ $0 | EDGAR |
| 2021-05-17 | 4/A | Miller James Charles — Director | Grant/award (A): 38,012 (derivative) @ $0 | EDGAR |
| 2021-05-17 | 4/A | Reasons Bryan M. — Director | Grant/award (A): 38,012 (derivative) @ $0 | EDGAR |
| 2021-05-17 | 4/A | Berelowitz Michael — Director | Grant/award (A): 38,012 (derivative) @ $0 | EDGAR |
| 2021-05-17 | 4/A | Ashton William — Director | Grant/award (A): 38,012 (derivative) @ $0 | EDGAR |
| 2021-05-17 | 4/A | HENWOOD GERALDINE — Director | Grant/award (A): 38,012 (derivative) @ $0 | EDGAR |
| 2021-04-22 | 4 | Miller James Charles — Director | Grant/award (A): 26,923 @ $0 · Grant/award (A): 38,012 (derivative) @ $0 | EDGAR |
| 2021-04-22 | 4 | Weisman Wayne — Director | Grant/award (A): 26,923 @ $0 · Grant/award (A): 38,012 (derivative) @ $0 | EDGAR |
| 2021-04-22 | 4 | CHURCHILL WINSTON J — Director | Grant/award (A): 26,923 @ $0 · Grant/award (A): 38,012 (derivative) @ $0 | EDGAR |
| 2021-04-22 | 4 | Reasons Bryan M. — Director | Grant/award (A): 26,923 @ $0 · Grant/award (A): 38,012 (derivative) @ $0 | EDGAR |
| 2021-04-22 | 4 | Berelowitz Michael — Director | Grant/award (A): 26,923 @ $0 · Grant/award (A): 38,012 (derivative) @ $0 | EDGAR |
| 2021-04-22 | 4 | Ashton William — Director | Grant/award (A): 26,923 @ $0 · Grant/award (A): 38,012 (derivative) @ $0 | EDGAR |
| 2021-04-22 | 4 | HENWOOD GERALDINE — Director | Grant/award (A): 26,923 @ $0 · Grant/award (A): 38,012 (derivative) @ $0 | EDGAR |
| 2021-04-15 | 4 | HENWOOD GERALDINE — Director | Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2021-04-12 | 4 | Lake Ryan David — Chief Financial Officer | Tax withholding (F): 5,172 @ $3.24 | EDGAR |
| 2021-02-12 | 4 | Miller James Charles — Director | Option exercise (M): 20,000 (derivative) @ $0 | EDGAR |
| 2021-02-12 | 4 | Lake Ryan David — Chief Financial Officer | Tax withholding (F): 1,075 @ $3.74 | EDGAR |
| 2021-01-20 | 4 | Lake Ryan David — Chief Financial Officer | Tax withholding (F): 1,352 @ $3.03 | EDGAR |
| 2021-01-20 | 4 | HENWOOD GERALDINE — Director | Option exercise (M): 5,000 · Tax withholding (F): 6,816 @ $3.03 · Option exercise (M): 5,000 (derivative) @ $0 | EDGAR |
| 2021-01-12 | 4 | Lake Ryan David — Chief Financial Officer | Grant/award (A): 36,000 @ $0 · Grant/award (A): 200,000 @ $0 · Grant/award (A): 30,000 · Tax withholding (F): 12,610 @ $2.99 | EDGAR |
| 2021-01-05 | 4 | Lake Ryan David — Chief Financial Officer | Tax withholding (F): 1,210 @ $3.09 | EDGAR |
| 2021-01-05 | 4 | HENWOOD GERALDINE — Director | Tax withholding (F): 5,599 @ $3.09 | EDGAR |
| 2020-12-28 | 4 | SCP Vitalife Partners (Israel) II, L.P. — 10% owner | Sale (S): 18,830 @ $3.17 | EDGAR |
| 2020-12-28 | 4 | SCP Vitalife Partners II LP — 10% owner | Sale (S): 56,375 @ $3.17 | EDGAR |
| 2020-12-22 | 4 | SCP Vitalife Partners (Israel) II, L.P. — 10% owner | Sale (S): 6,208 @ $3.03 | EDGAR |
| 2020-12-22 | 4 | SCP Vitalife Partners II LP — 10% owner | Sale (S): 18,587 @ $3.03 | EDGAR |
| 2020-12-18 | 4 | Lake Ryan David — Chief Financial Officer | Grant/award (A): 79,208 @ $0 · Grant/award (A): 116,505 (derivative) @ $0 | EDGAR |
| 2020-12-18 | 4 | ENLOE J DAVID JR — Chief Executive Officer, Director | Grant/award (A): 19,802 @ $0 · Grant/award (A): 132,013 @ $0 · Grant/award (A): 194,175 (derivative) @ $0 | EDGAR |
Recent 8-K events — Recro Pharma, Inc.
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2024-04-08 | 8-K | 1.02 — Termination of a Material Definitive Agreement 2.01 — Completion of Acquisition or Disposition of Assets 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 3.03 — Material Modification to Rights of Security Holders 5.01 — Changes in Control of Registrant 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-03-15 | 8-K | 8.01 — Other Events | EDGAR |
| 2024-02-28 | 8-K | 1.01 — Entry into a Material Definitive Agreement 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-11-28 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-11-08 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-09-20 | 8-K | ? 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-08-28 | 8-K | 1.01 — Entry into a Material Definitive Agreement 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-08-23 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2023-08-14 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-05-26 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=REPH returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs